GTBPVSPECO• 28 Days (Normalized)
GTBP vs PECO (GT Biopharma Inc. vs Phillips Edison & Company Inc.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+2431.12%
GT Biopharma Inc.
Normalized Baseline0.00%
PECO Performance $37.76
-3.08%
Phillips Edison & Company Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+2434.2 pts
GTBP outperforming by 2434.20 percentage points
GTBPPECO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP PECO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | GTBP Price | GTBP Gain (%) | PECO Price | PECO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +2431.12% | $37.76 | -3.08% | +2434.20% |
| Sep 29, 2026 | $6.88 | +2752.70% | $- | - | |
| Sep 28, 2026 | $6.80 | +2721.58% | $37.54 | -3.64% | +2725.22% |
| Sep 25, 2026 | $6.89 | +2758.92% | $37.39 | -4.03% | +2762.95% |
| Sep 24, 2026 | $6.83 | +2734.02% | $37.12 | -4.72% | +2738.74% |
| Sep 23, 2026 | $7.10 | +2846.06% | $36.72 | -5.75% | +2851.81% |
| Sep 22, 2026 | $- | $37.09 | -4.80% | - | |
| Sep 21, 2026 | $7.18 | +2879.25% | $37.00 | -5.03% | +2884.28% |
| Sep 18, 2026 | $7.16 | +2870.95% | $37.16 | -4.62% | +2875.57% |
| Sep 17, 2026 | $7.49 | +3007.88% | $37.36 | -4.11% | +3011.99% |
| Sep 16, 2026 | $7.81 | +3140.66% | $37.80 | -2.98% | +3143.64% |
| Sep 15, 2026 | $9.00 | +3634.44% | $37.98 | -2.52% | +3636.96% |
| Sep 14, 2026 | $11.63 | +4725.73% | $38.41 | -1.41% | +4727.14% |
| Sep 11, 2026 | $8.61 | +3472.61% | $38.41 | -1.41% | +3474.02% |
| Sep 10, 2026 | $6.18 | +2464.32% | $38.72 | -0.62% | +2464.94% |
Page 1 of 2